Concepedia

J. Ing

JI

Statistics

Publications

4

Citations

365

H-Index

4

Active since

2006

Affiliations

Pinnacle Oncology Hematology(Current)

University of Colorado Denver

J. Ing is an author at Pinnacle Oncology Hematology specializing in cancer pharmacology, pharmacology, and apoptotic signaling.

Publications per year

2006–2010

4

Publications

4

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

D. Ross Camidge, Roy S. Herbst, Michael S. Gordon et al. · Clinical Cancer Research · 2010 · 169 citations

, , +17

A phase I safety and pharmacokinetic (PK) study of recombinant Apo2L/TRAIL, an apoptosis-inducing protein in patients with advanced cancer

Roy S. Herbst, D. S. Mendolson, Scot Ebbinghaus et al. · Journal of Clinical Oncology · 2006 · 93 citations

, , +16

A phase IB safety and pharmacokinetic (PK) study of recombinant human Apo2L/TRAIL in combination with rituximab in patients with low-grade non-Hodgkin lymphoma

Lorrin Yee, Michelle A. Fanale, K. Dimick et al. · Journal of Clinical Oncology · 2007 · 65 citations

, , +17

A phase I safety and pharmacokinetic study of apomab, a human DR5 agonist antibody, in patients with advanced cancer

D. Ross Camidge, Roy S. Herbst, Michael S. Gordon et al. · Journal of Clinical Oncology · 2007 · 38 citations

, , +17

1–4 of 4